RT Journal Article
SR Electronic
T1 Modeling and Preparedness: The Transmission Dynamics of COVID-19 Outbreak in Provinces of Ecuador
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.09.20150078
DO 10.1101/2020.07.09.20150078
A1 Bustamante-Orellana, Carlos
A1 Cevallos-Chavez, Jordy
A1 Montalvo-Clavijo, Cesar
A1 Sullivan, Jeff
A1 Michael, Edwin
A1 Mubayi, Anuj
YR 2020
UL http://medrxiv.org/content/early/2020/07/11/2020.07.09.20150078.abstract
AB Coronavirus disease 2019 (COVID-19), a novel infectious disease first identified in December 2019 in the city of Wuhan of China’s Hubei province, is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease has become a pandemic in just a few months and spread globally with more than 2.89 million cases and 203,000 deaths across 185 countries, as of April 26th, 2020. Ecuador has reported one of the highest rates of COVID-19 in Latin America, with more than 10K cases and 500 deaths in a country of approximately 17 million people. The dynamics of the outbreak is being observed quite different in different provinces of Ecuador with high reported prevalence in some low population density provinces. In this study, we aim to understand variations in outbreaks between provinces and provide assistance in essential preparedness planning in order to respond effectively to ongoing COVID-19 outbreak. The study estimated the critical level of quarantine rate along with corresponding leakage in order to avoid overwhelming the local health care system. The results suggest that provinces with high population density can avoid a large disease burden provided they initiate early and stricter quarantine measures even under low isolation rate. To best of our knowledge, this study is first from the region to determine which provinces will need much preparation for current outbreak in fall and which might need more help.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialIN this study there is no clinical trialsFunding StatementNo funding support.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This is modeling study which did not collect data from field.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are included in the manuscript